Caltrate 500 mg / 1000 IU, chewable tablets *
Company:
GlaxoSmithKline Consumer Healthcare (Ireland) LtdStatus:
No Recent UpdateLegal Category:
Supply through pharmacy onlyActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 03 March 2021
File name
7001_Caltrate Chewable_SmPC_20_346_November 2020_clean_1614772536.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 03 March 2021
File name
7001_Caltrate Chewable_PIL_20_346_November 2020_clean_1614772454.pdf
Reasons for updating
- Change to section 2 - excipient warnings
- Change to section 6 - date of revision
Updated on 30 November 2020
File name
1571_Caltrate Chewable_SmPC_20_022_August 2020_1606733414.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Supply through pharmacy only
Updated on 30 November 2020
File name
1571_Caltrate chewable_PIL_20_022_77157B_Oct 2020_1606733314.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 11 March 2019
File name
7001_ PIL_16 023_PAA77157A_1552315959.pdf
Reasons for updating
- New PIL for new product
Updated on 11 March 2019
File name
7001_SmPC_16 023_v1_1552316220.pdf
Reasons for updating
- New SPC for new product
Legal category:Supply through pharmacy only